Population pharmacokinetics of vancomycin in patients receiving extracorporeal membrane oxygenation
about
Pharmacotherapy during pediatric extracorporeal membrane oxygenation: a review.Vancomycin dosing assessment in intensive care unit patients based on a population pharmacokinetic/pharmacodynamic simulation.Vancomycin population pharmacokinetics during extracorporeal membrane oxygenation therapy: a matched cohort studyPediatric cardiovascular drug dosing in critically ill children and extracorporeal membrane oxygenationClinical pharmacokinetics of vancomycin in the neonate: a reviewPharmacokinetics and safety of fluconazole in young infants supported with extracorporeal membrane oxygenation.Trough Concentrations of Vancomycin in Patients Undergoing Extracorporeal Membrane Oxygenation.The impact of extracorporeal life support and hypothermia on drug disposition in critically ill infants and children.Pharmacokinetics of Continuous Infusion Meropenem With Concurrent Extracorporeal Life Support and Continuous Renal Replacement Therapy: A Case Report.External Evaluation of Population Pharmacokinetic Models of Vancomycin in Neonates: The transferability of published models to different clinical settings.Sequestration of drugs in the circuit may lead to therapeutic failure during extracorporeal membrane oxygenationA Population Pharmacokinetic Model for Vancomycin in Adult Patients Receiving Extracorporeal Membrane Oxygenation TherapyVancomycin: a review of population pharmacokinetic analyses.A systematic review on pharmacokinetic changes in critically ill patients: role of extracorporeal membrane oxygenation.Drug absorption, distribution, metabolism and excretion considerations in critically ill adults.Predictive performance of reported population pharmacokinetic models of vancomycin in Chinese adult patients.Developmental pharmacokinetics in neonates.Pharmacokinetic considerations for drugs administered in the critically ill.How to use vancomycin optimally in neonates: remaining questions.Pharmacometric Approaches to Personalize Use of Primarily Renally Eliminated Antibiotics in Preterm and Term Neonates.Pharmacokinetics and Dosing of Anti-infective Drugs in Patients on Extracorporeal Membrane Oxygenation: A Review of the Current Literature.Evaluation of Altered Drug Pharmacokinetics in Critically Ill Adults Receiving Extracorporeal Membrane Oxygenation.Population pharmacokinetics of vancomycin in adult Chinese patients with post-craniotomy meningitis and its application in individualised dosage regimens.Pharmacokinetics of Vancomycin in Elderly Patients Aged over 80 Years.Therapeutic drug monitoring of continuous-infusion acylovir for disseminated herpes simplex virus infection in a neonate receiving concurrent extracorporeal life support and continuous renal replacement therapy.Pharmacotherapy during neonatal extracorporeal membrane oxygenation: toward an evidence-based approachDeterminants of drug absorption in different ECMO circuits.Vancomycin Dosing in Pediatric Extracorporeal Membrane Oxygenation: Potential Impacts of New Technologies.Antifungal Extraction by the Extracorporeal Membrane Oxygenation Circuit.Nephrotoxicity in patients with vancomycin trough concentrations of 15-20 μg/ml in a pediatric intensive care unit.Population pharmacokinetics of vancomycin in Thai patients.Pharmacokinetics of continuous-infusion meropenem in a pediatric patient receiving extracorporeal life support.Pharmacokinetics of oseltamivir and oseltamivir carboxylate in critically ill patients receiving continuous venovenous hemodialysis and/or extracorporeal membrane oxygenation.Drugs pharmacokinetics during veno-venous extracorporeal membrane oxygenation in pediatrics.Optimising drug dosing in patients receiving extracorporeal membrane oxygenation.
P2860
Q30249512-879E99C6-C309-4483-A046-326EC2E1BDC7Q34026240-B3632D4F-1803-4352-BD8C-8D296E63327FQ34636783-9D29C389-B8AB-4253-A058-F43270BF72B3Q35161181-54C479C7-F7D9-48E8-AAF1-8E57DA1933A2Q36104107-E569EB86-38FF-43DE-8847-F7222912703BQ36240580-23B8C90E-269B-4926-866F-D2904296EDAAQ36257532-CDFAD731-7EA0-4436-8E0A-1213E2B28F7AQ36452379-D04383CA-69BC-4E2A-8728-C77CB01B6AC7Q36652824-283D33BD-ABB6-4830-843E-094B1B1DECF7Q36729959-6EF97F5E-65FE-4DA5-8F53-7529AD0ECE20Q36928231-3ADC3826-2903-42F9-8D27-CA7326F4FCF1Q37283031-3133F247-042D-473A-B92B-BE3FBD7CC98DQ37965578-225B5788-7333-4FD7-BDF1-C8CAFAC6F93DQ38012111-687F908D-70AA-42B0-BEAF-4932EBC25B00Q38107537-D788329F-C25B-4052-9BDF-8A0630ED690CQ38137251-4BF8A627-BBBD-4B2A-9DDA-5E752D291D4AQ38178316-B75AABC8-E495-487A-9350-86B894B80691Q38351793-60DABC26-2769-471A-899E-AC0F56404F40Q38569678-69D19258-DDBC-4767-ACC2-60A9DC68868AQ38696468-436F33C8-3942-4439-9629-4589D77D717BQ38935160-602383D2-FF11-4643-84D7-2BF07FC6419DQ39033001-C2815EC6-D6C9-4B82-8CB5-833923203F5EQ40481176-FE839360-72CF-4A06-B0B9-D63D985DE88DQ40672214-E49376F1-1E2E-46CE-86BC-5350F63ECB90Q41564809-8A5FDADE-8F61-4F68-BEA2-C0D04688E09AQ41770419-2C725BA6-BD43-45B1-A000-04F28D406952Q42362818-16BDC9BA-6C17-4518-B475-EEB0EFF454A8Q42376928-2FCB1386-DE88-4854-AF11-8E1E5BEF8FE7Q45069269-442A7BF7-4ACF-4DAF-95E5-AABB9BC17915Q45329118-EB6CFB1A-E867-4EF1-B08A-0779BEAE2998Q51372806-4ECA8A9C-EE0C-400C-A995-CF4F0DC5A9F6Q51702479-2EC2814C-4EE9-4CD3-99A2-55C9E16D4AC4Q53351375-187DED7C-9223-409A-B7BA-67AB5F16CC3AQ55145216-F5A7830E-A92F-485A-A0CF-2DACD6E17ADEQ55393633-CA559664-2BC9-4F3D-A986-83C405E583B5
P2860
Population pharmacokinetics of vancomycin in patients receiving extracorporeal membrane oxygenation
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Population pharmacokinetics of ...... corporeal membrane oxygenation
@ast
Population pharmacokinetics of ...... corporeal membrane oxygenation
@en
type
label
Population pharmacokinetics of ...... corporeal membrane oxygenation
@ast
Population pharmacokinetics of ...... corporeal membrane oxygenation
@en
prefLabel
Population pharmacokinetics of ...... corporeal membrane oxygenation
@ast
Population pharmacokinetics of ...... corporeal membrane oxygenation
@en
P2860
P1476
Population pharmacokinetics of ...... corporeal membrane oxygenation
@en
P2093
Hussain Mulla
Suneel Pooboni
P2860
P304
P356
10.1111/J.1365-2125.2005.02432.X
P407
P577
2005-09-01T00:00:00Z